HK2 and Miyoshi myopathy: HK2, an isoform of hexokinase that is overexpressed in many malignancies including MM [45], is another promising target in myeloma given that small-drug inhibition of HK2 [46] or knockdown of HK2 using anti-sense oligonucleotides [47] kills neoplastic plasma cells with great efficacy.